Monitoring of the IOP After SLT Using iCare Home
Launched by ST. ERIK EYE HOSPITAL · Oct 10, 2017
Trial Information
Current as of May 14, 2025
Unknown status
Keywords
ClinConnect Summary
Sixty glaucoma patients (POAG and PEX) planned for SLT will be recruited.
At baseline, patients will be trained to use the iCare Home tonometer, a handheld device based on rebound tonometry and designed for patients to use at home. After the training session and when patients feel confident, a measurement will be recorded. Thereafter, a new measurement will be obtained by the study staff (an optometrist or a nurse) using the same device. No IOP values will be visible for the examiner at that point. Thereafter, a single IOP measurement will be obtained by the same study staff using Goldmann...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • POAG
- • PXG
- Exclusion Criteria:
- • previous SLT
- • reduced hand and arm mobility (e.g. due to rheumatism)
About St. Erik Eye Hospital
St. Erik Eye Hospital is a leading specialized ophthalmic center dedicated to advancing eye care through innovative research and clinical trials. As a prominent sponsor of ophthalmology studies, the hospital focuses on enhancing patient outcomes by exploring new treatment modalities and technologies. With a commitment to excellence in patient care and a collaborative approach involving multidisciplinary teams, St. Erik Eye Hospital strives to contribute significantly to the field of vision science and improve the quality of life for individuals with various eye conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Trial Officials
Enping Chen, MD Ph D
Principal Investigator
St. Erik Eye Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials